Subject of the day
FTRE
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
FY 2023–2025 · 3 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $2.70B | -6.9% | |
| Operating income | -$872.60M | +196.5% | |
| Net income | -$328.50M | — | |
| Cash from ops | $262.80M | +73.3% |
$17.82
▼ -0.51 (-2.8%)
| 52w hi | $20.70 |
|---|---|
| 52w lo | $7.31 |
| Vol | 1.28M |
| As of | Aug 13 |
Our score -0.10
| Short | -0.01 |
|---|---|
| Medium | -0.00 |
| Long | -0.48 |
computed 2026-08-13
Fortrea Holdings Inc.
Healthcare · Biotechnology
| Market cap | $1.69B |
|---|---|
| Enterprise value | $2.69B |
| Trailing P/E | — |
| Forward P/E | 15.65x |
| EV / EBITDA | 27.39x |
| P / S (ttm) | 0.63x |
| Profit margin | -3.2% |
| Return on equity | -15.3% |
| Revenue growth | -4.5% |
| Earnings growth | — |
| Debt / equity | 213.24 |
| Beta vs SPX | 1.86 |
|---|---|
| Corr SPX | 0.36 |
| Annual vol | 84.1% |
| Annual ret | +17.5% |
| Sharpe | 0.21 |
| Max DD | -83.9% |
Window: 504 trading days (504 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | -0.10 | |
| Sector | +0.12 | |
| Technical | +0.00 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $18.52 | $18.68 | $17.71 | $17.82 | 1.28M |
| Aug 12 | $19.33 | $19.35 | $18.30 | $18.33 | 1.66M |
| Aug 11 | $18.94 | $19.58 | $18.82 | — | 862.63K |
| Aug 10 | $18.12 | $19.28 | $17.91 | $18.99 | 1.04M |
| Aug 7 | $17.86 | $18.58 | $17.58 | $18.43 | 989.70K |